Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

News

Author: Simge Eva DoganPublished: 7 November 2018

Prep: Cook: Serves:

Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions.

The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year.

Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising programs.”

To read more on this topic click here.

For more information on Parkinson’s treatments please visit the EPDA website

New smart glasses could track Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Global update

5 Christmas gifts for people with Parkinson’s

Our readers recommend the perfect presents this Christmas

Magnesium, muscles and Parkinson’s

Our guest dietician Kathrynne Holden shares her expertise

Parkinson’s and depression: it’s not all in your mind

The causes of and treatments for depression and Parkinson’s disease

Researchers are developing an autonomous vehicle for people with Parkinson’s disease

For some people with Parkinson’s, managing regular visits to healthcare professionals may prove challenging. Now, researchers from the University of Michigan, US, are developing an autonomous vehicle prototype designed specifically to help those living with the condition. Autonomous vehicles are defined by what a driver is exempt from doing in safety-critical situations, including braking and steering. “A recurring theme that has come up is that people with Parkinson’s disease have different lifestyles, but they share the desire to carry out tasks independently,” said Nathaniel Miller, associate professor of psychology at the University of Michigan-Flint, in a press release. To help address this issue, the project – currently in the early stages – will involve creating simulated driving scenarios in labs to inform the prototype car’s design. The researchers hope to understand which vehicle features people with Parkinson’s prefer, how to reduce barriers to entering and exiting cars and how to improve…

Parkinson’s disease genes activated in zebrafish exposed to aluminium

According to research on zebrafish in Naples, Italy, aluminium exposure may increase the activity of several genes associated with the development of Parkinson’s. The team investigated the impact of exposing zebrafish to aluminium for periods of 10, 15 or 20 days. Subsequent analyses revealed that effects in “cellular disorganisation” and swelling, brought on by the exposure, were highest after 10 or 15 days – and that around 10 Parkinson’s-related genes showed increased signs of activation. The researchers found that while fish exposed to aluminium showed signs of brain degeneration, brain tissue remained intact in the fish that were not exposed. When their results were published in the journal ‘Chemosphere’, the researchers noted that further investigation of the link between aluminium exposure and Parkinson’s is needed – but they wrote: “Overall, the data confirm the neurotoxicity induced by aluminium and shed a light on its involvement in neurodegenerative processes.”

Could wearable heart sensors help with diagnosing Parkinson’s disease?

Decreased heart rate variability (HRV) – that is, reduced time between heartbeats – has previously been associated with a greater risk of Parkinson’s. Now, researchers in Japan have suggested that using wearable sensors to measure this variability may help in diagnosing the condition at its early stages. As part of their study, the team analysed the heart rate variability of 27 people with Parkinson’s and 23 without the condition. The participants wore two heart rate sensors on their wrists for approximately 24 hours during a hospital stay. Results from the study showed that heart rate variability was “significantly decreased” in people with Parkinson’s, with the researchers reporting that the “assessment method was effective in detecting decreased HRV”. Noting the need for further research, the team wrote: “Our wearable sensor-based analysis should also be tested in subjects at the [early] stages” to determine the applicability for early diagnosis of Parkinson’s.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

News

Author: Simge Eva DoganPublished: 7 November 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

5 Christmas gifts for people with Parkinson’s

Recipes & Nutrition

Magnesium, muscles and Parkinson’s

Special reports

Parkinson’s and depression: it’s not all in your mind

Researchers are developing an autonomous vehicle for people with Parkinson’s disease

Parkinson’s disease genes activated in zebrafish exposed to aluminium

Could wearable heart sensors help with diagnosing Parkinson’s disease?

{title}

Subscribe

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

News

Author: Simge Eva DoganPublished: 7 November 2018

Last Month

Next Month

Share this story

Comments

Related articles

Global update

5 Christmas gifts for people with Parkinson’s

Recipes & Nutrition

Magnesium, muscles and Parkinson’s

Special reports

Parkinson’s and depression: it’s not all in your mind

Researchers are developing an autonomous vehicle for people with Parkinson’s disease

Parkinson’s disease genes activated in zebrafish exposed to aluminium

Could wearable heart sensors help with diagnosing Parkinson’s disease?

{title}

Subscribe

Sign in